Loading cover... Drag cover to reposition
MCV 5-dose implementation

MCV 5-dose implementation

Files
Timeline
About
Albums
Discussions
Events
Members
Announcements
Videos
Audio

Group Resources

Gavi Budget Eligibility Guide

Sassenach 2nd June 2023 119

Gavi Vaccine Funding Guidelines

Sassenach 2nd June 2023 117

Gavi Budgeting Reporting Template

Sassenach 2nd June 2023 119

Gavi Measles Containing Vaccine Presentation Switch Request Form

Sassenach 2nd June 2023 113

La transition du MCV en 10 doses à 5 doses en Inde

Sassenach 21st April 2023 114

5 doses ressource d’une page

Sassenach 21st April 2023 109

5 doses en l'Asie et le Pacifique

Sassenach 21st April 2023 107

5 doses en Afrique_ 2023

Sassenach 21st April 2023 121

Outil d'aide à l'évaluation pour le passage au flacon de 5 doses de VAR

Sassenach 21st April 2023 108

MCV 5-dose Vial Assessment Support Tool

Sassenach 4th April 2023 141

[DUPLICATE] MCV 5-dose Vial Assessment Support Tool

Sassenach 4th April 2023 101

WHO SEARO meeting report (August 2022)

Sassenach 5th December 2022 92

WHO AFRO RITAG meeting report (July 2020)

Sassenach 5th December 2022 87

MCV 5-dose in Asia Pacific (Nov. 2022)

Sassenach 5th December 2022 89

MCV 5-dose in Africa Map (Nov. 2022)

Sassenach 5th December 2022 98

WHO/UNICEF Fact Sheet on Measles and Rubella 5-dose (Updated Sept. 2022)

Sassenach 5th December 2022 119

UNICEF-WHO MCV 5-dose Fact Sheet (Updated Aug. 2022)

Sassenach 5th December 2022 86

Vaccine Hesitancy among Parents and Its Association with the Uptake of Measles Vaccine in Urban Settings in Khartoum State, Sudan (Bosma et al., 2022)

Sassenach 28th July 2022 123

Ethiopia Total Systems Effectiveness Analysis (TSE). Linksbridge/Sassenach, 2022.

Sassenach 12th July 2022 120

Dose Per Container Partnership Immunization decision support resource. DPCP, 2019.

Sassenach 12th July 2022 112

Filters